George K. Ng - 08 Aug 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Executive Officer
Signature
/s/ George Ng, by Neda A. Sharifi, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
08 Aug 2023
Net transactions value
$0
Form type
4
Filing time
09 Aug 2023, 16:51:20 UTC
Next filing
25 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Units Award $0 +400,000 $0.000000 400,000 08 Aug 2023 Common Stock 400,000 $0.000000 Direct F1
transaction PCSA Restricted Stock Units Award $0 +400,000 +100% $0.000000 800,000 08 Aug 2023 Common Stock 400,000 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting of one-third on 08/08/24, 08/08/25, and 08/08/26 or upon a change in control event.
F2 The restricted stock units vest upon the achievement of certain performance goals.